好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

MRI findings and evolution of active or calcified cysts in treated and untreated patients with neurocysticercosis
Infectious Disease
P5 - Poster Session 5 (5:30 PM-6:30 PM)
4-035
To evaluate the frequency of hippocampal atrophy (HA), clinical evolution and whether the imaging findings are related to the occurrence of epileptic seizures in patients with Neurocysticercosis.

Neurocysticercosis (NCC) is the most common parasitic infection of the Central Nervous System (CNS). A frequent cause of reactive seizures and epilepsy worldwide. In the last decades, several studies have suggested an association between NCC and hippocampal atrophy (HA). New Magnetic Resonance (MRI) techniques allowed more detailed evaluation of cystic lesions, inflammatory response and other associated abnormalities.

  

Patients followed outpatient clinics due to epilepsy or cephalgia and NCC, were evaluated through clinical and imaging data (MRI). They were classified as treated and not treated for NCC (albendazole or praziquantel). The presence of hippocampal atrophy was evaluated through the online volBrain program (http://volbrain.upv.es), using as reference the mean of the hippocampus of healthy individuals, defined as the control group. We defined the evolution of the cysts and/or other parenchymal alterations through the visual analysis of the MRI.

Data analysis was performed using SPSS software. For the quantitative variables, we performed the normality test (Kolmogorov-Smirnov), followed by non-parametric tests (Mann-Whitney or Kruskal-Wallis). The chi-square (x2) or Fisher's test were used to analyze the categorical variables.

we evaluated 181 individuals (70 cases and 111 controls). Hippocampal volumes were different between cases and controls (p<0.001). 70% of the cases presented HA. 52.2% of the patients without history of treatment for NCC had reports of epileptic seizures. There was an association between non-treatment and the occurrence of epileptic seizures (p=0.006). 72.7% of the patients had signs of edema around the calcified lesion(s). There was an association between perilesional edema and the presence of epileptic seizures (p=0,004).

Hippocampal atrophy is frequent in patients with NCC.

There was an association between non-treatment, perilesional edema and the occurrence of epileptic seizures.

 

Authors/Disclosures

PRESENTER
No disclosure on file
Fernando Cendes, MD, PhD, FAAN (Departamento de Neurologia; FCM; UNICAMP) Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Leticia Franceschet Ribeiro No disclosure on file